Podcasts about american society

"We proposed a concept to the American Society of Clinical Oncology (ASCO), recognizing that extravasation management requires significant interdisciplinary collaboration and rapid action. There can occasionally be uncertainty or lack of clear guidance when an extravasation event occurs, and our objective was to look at this evidence with the expert panel to create a resource to support oncology teams overall. We hope that the guideline can help mitigate harm and improve patient outcomes," Caroline Clark, MSN, APRN, AGCNS-BC, OCN®, EBP-C, director of guidelines and quality at ONS, told Chelsea Backler, MSN, APRN, AGCNS-BC, AOCNS®, VA-BC, oncology clinical specialist at ONS, during a conversation about the ONS/ASCO Guideline on the Management of Antineoplastic Extravasation. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by January 2, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to the management of antineoplastic extravasation. Episode Notes  Complete this evaluation for free NCPD. ONS/ASCO Guideline on the Management of Antineoplastic Extravasation ONS Podcast™ episodes: Episode 391: Pharmacology 101: Antibody–Drug Conjugates Episode 335: Ultrasound-Guided IV Placement in the Oncology Setting Episode 145: Administer Taxane Chemotherapies With Confidence Episode 127: Reduce and Manage Extravasations When Administering Cancer Treatments ONS Voice articles: Access Devices and Central Lines: New Evidence and Innovations Are Changing Practice, but Individual Patient Needs Always Come First New Extravasation Guidelines Provide Recommendations for Protecting Patients and Standardizing Care Standardizing Venous Access Assessment and Validating Safe Chemo Administration Drastically Lowers Rates of Adverse Venous Events This Organization's Program Trains Non-Oncology Nurses to Deliver Antineoplastic Agents Safely ONS books: Access Device Guidelines: Recommendations for Nursing Practice and Education (fourth edition) Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (second edition) Clinical Guide to Antineoplastic Therapy: A Chemotherapy Handbook (fourth edition) ONS courses: Complications of Vascular Access Devices (VAD) and IV Therapy ONS Fundamentals of Chemotherapy and Immunotherapy Administration™ ONS Oncology Treatment Modalities Clinical Journal of Oncology Nursing articles: Chemotherapy Extravasation: Incidence of and Factors Associated With Events in a Community Cancer Center Standardized Venous Access Assessment and Safe Chemotherapy Administration to Reduce Adverse Venous Events Oncology Nursing Forum article: Management of Extravasation of Antineoplastic Agents in Patients Undergoing Treatment for Cancer: A Systematic Review ONS huddle cards: Antineoplastic Administration Chemotherapy Immunotherapy Implanted Venous Port ONS position statements: Administration (Infusion and Injection) of Antineoplastic Therapies in the Home Education of the Nurse Who Administers and Cares for the Individual Receiving Antineoplastic Therapies ONS Guidelines™ for Extravasation Management ONS Oncologic Emergencies Learning Library ONS/ASCO Algorithm on the Management of Antineoplastic Extravasation of Vesicant or Irritant With Vesicant Properties in Adults American Society of Clinical Oncology (ASCO) Podcast: Management of Antineoplastic Extravasation: ONS-ASCO Guideline To discuss the information in this episode with other oncology nurses, visit the ONS Communities.  To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "The focus of this guideline was specifically on intravenous antineoplastic extravasation or when a vesicant or an irritant with vesicant properties leaks out of the vascular space. This can cause an injury to the patient that's influenced by several factors including the specific drug that was involved in the extravasation, whether it was DNA binding, how much extravasated, the affected area, and individual patient characteristics." TS 1:48 "The panel identified and ranked outcomes that mattered most with extravasation. Not surprising, one of the first was tissue necrosis. Like, 'How are we going to prevent tissue necrosis and preserve tissue?' The next were pain, quality of life, delays in cancer treatment: How is an extravasation going to delay cancer treatment that's vital to the patient? Is an extravasation also going to result in hospitalization or additional surgical interventions that would be burdensome to the patient? ... We had a systematic review team that then went in and summarized the data, and the panel applied the grading of recommendations, assessment, development, and evaluation (GRADE) criteria, grading quality of evidence and weighing factors like patient preferences, cost, and feasibility of an intervention. From there, they developed their recommendations." TS 7:35 "The panel, from the onset, wanted to make sure we had something visual for our readers to reference. They combined evidence from the systematic review, other scholarly sources, and their real-world clinical experience to make this one-page supplementary algorithm. They wanted it to be comprehensive and easy to follow, and they included not only those acute management steps but also guidance on 'How do I document this and what are the objective and subjective assessment factors to look at? What am I going to tell the patient?' In practice, for use of that, I would compare it to your current processes and identify any gaps to inform policies in your individual organizations." TS 16:34 "The guidelines don't take place of clinician expertise; they're not intended to cover every situation, but a situation that keeps coming up that we should talk about as a limitation, is we're seeing these case reports of tissue injury with antibody–drug conjugate extravasation. There's still not enough evidence to inform care around the use of antidotes with those agents, so this still needs to be addressed on a case-by-case basis. We still need publication of those case studies, what was done, and outcomes to help inform direction." TS 19:24 "Beyond the acute management is to ensure thorough documentation regarding extravasation. Whether you're on electronic documentation or on paper, are the prompts there for the nurse to capture all of the factors that should be captured regarding that extravasation? The size, the measurement, the patient's complaints. Is there redness? Things like that. And then within the teams, everyone should know where to find that initial extravasation assessment so that later on, if they're in a different clinic, they have something to go by to see how the extravasation is healing or progressing. ... I think there's an importance here, too, to our novice oncology nurses and their preceptors. This could be anxiety-provoking for the whole team and the patient, so we want to increase confidence in management. So, I think using these resources for onboarding novice oncology nurses is important." TS 22:34

For over 20 years, Shannon and her team at Tristar Pension Consulting have acted as a secret weapon for financial advisors, CPAs, small businesses, and plan sponsors. They are the go-to resource for plan design, fixing broken retirement plans, client presentation support, and high-touch customer service.Since starting the firm over two decades ago, her goal has been to provide a deeper level of retirement plan knowledge and service for clients, as well as a flexible workplace for employees. Today, they are one of the leading providers of retirement plan administration for small businesses.Shannon is a credentialed member of the American Society of Pension Professionals and Actuaries (ASPPA) and the National Institute of Pension Administrators (NIPA). She currently serves on the ASPPA Leadership Council and as the current year's President. She has also served on several fundraising committees and supports many non-profits locally, such as Infant Crisis Services, Make a Wish Oklahoma, and Cleats for Kids.If you are a financial advisor, CPA, or business owner with retirement plan questions, please be sure to connect with Shannon on LinkedIn. You can also email her at shannon@tristarpension.com.The podcast mentions a resource on the Tristar Pension webpage. It is available at - https://www.tristarpension.com/tpa/compliance-administration-checklist In this episode, Eric and Shannon Edwards discuss:Understanding fiduciary roles clearlyEvaluating service providers carefullyComparing plan structures strategicallyBuilding knowledge and relationships proactivelyKey Takeaways:Different fiduciary types—3(16), 3(21), 3(38), and 402(a)—carry distinct responsibilities and authority levels. Plan sponsors must still monitor and fulfill their duties, even when delegating to these fiduciaries.Reading service agreements and using checklists clarifies who does what and prevents misunderstandings. Tools like the ARA TPA Checklist help sponsors ask better questions and assess compliance partners effectively.Pooled Employer Plans (PEPs) can expand access but may introduce higher costs, operational complexity, and exit challenges. Sponsors should weigh total cost, services, and fiduciary responsibilities when choosing between PEPs and standalone plans.New benefits managers and advisors benefit from targeted education and responsive compliance partners. Continuous learning and relationship-building ensure fiduciary effectiveness and confident plan management.“Your fiduciary duties are not gone. You are still submitting contributions, you are still supposed to be monitoring your 3(16) fiduciary, you're still supposed to be checking to make sure things are done properly.” - Shannon EdwardsConnect with Shannon Edwards:Website: https://www.tristarpension.com/ LinkedIn: https://www.linkedin.com/in/shannonedwardsplanconsultant/ Connect with Eric Dyson: Website: https://90northllc.com/Phone: 940-248-4800Email: contact@90northllc.com LinkedIn: https://www.linkedin.com/in/401kguy/ The information and content of this podcast are general in nature and are provided solely for educational and informational purposes. It is believed to be accurate and reliable as of the posting date, but may be subject to change.It is not intended to provide a specific recommendation for any type of product or service discussed in this presentation or to provide any warranties, investment advice, financial advice, tax, plan design, or legal advice (unless otherwise specifically indicated). Please consult your own independent advisor as to any investment, tax, or legal statements made.The specific facts and circumstances of all qualified plans can vary, and the information contained in this podcast may or may not apply to your individual circumstances or to your plan or client plan-specific circumstances.

Experts decode American Society of Nephrology (ASN) 2025 immunoglobulin A (IgA) nephropathy trials: B‑cell therapies, who benefits, and practical steps to improve patient care. Credit available for this activity expires: 12/24/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/navigating-advances-iga-nephropathy-key-developments-2025a100105j?ecd=bdc_podcast_libsyn_mscpedu

From Season 2 – Unsure of the next step in your career path? Madelyn Mackie shares her tips for deciding where you want to go and how to get there, so you can land your dream job. Recorded at EA Ignite Fall 2023 and produced by the American Society of Administrative Professionals - ASAP. Learn more and submit a listener question at asaporg.com/podcast.

As we close out 2025, I'm celebrating you—my listeners—by revisiting the year's most popular episodes. This isn't just a highlight reel; it's a roadmap to understanding why sustainable weight loss requires more than willpower. I'm sharing the most impactful insights from 2025 that tackle the hidden barriers blocking your progress: stress hormones storing belly fat, sleep deprivation hijacking your hunger signals, and the surprising truth about fructose damaging your liver and kidneys. In this special compilation episode, I break down the science behind the struggles and give you actionable strategies that actually work in real life. If weight loss feels harder than it should—even when you're doing everything "right"—this episode reveals why.   Featured Episodes: Episode 218: How Fructose Impacts Your Liver, Heart, and Kidneys Episode 206: Why the Scale Isn't Moving: 5 Hidden Weight Loss Blockers You Need to Know Episode 187: Breaking the Burnout Cycle with Dr. Judy Wright Episode 212: Game Changer: WeGovy Wins FDA Approval for Fatty Liver Disease Episode 219: Microdosing GLP-1s: Does It Actually Work?   Connect with Dr. Alicia Shelly: Website | drshellymd.com Facebook | www.facebook.com/drshellymd Instagram | @drshellymd Linked In | www.linkedin.com/in/drshellymd Twitter | @drshellymd   About Dr. Alicia Shelly Dr. Alicia Shelly was raised in Atlanta, GA. She received her Doctorate of Medicine from Case Western Reserve University School of Medicine in Cleveland, OH.  Dr. Shelly has been practicing Primary Care and Obesity medicine since 2014.  In 2017, she became a Diplomat of the American Board of Obesity Medicine. She is the lead physician at the Wellstar Medical Center Douglasville. She started a weekly podcast & Youtube channel entitled Back on Track: Achieving Healthy Weight loss,  where she discusses how to get on track and stay on track with your weight loss journey. She has spoken for numerous local and national organizations, including the Obesity Medicine Association, and the Georgia Chapter of the American Society of Metabolic and Bariatric Surgeons. She has been featured on CNN, Fox 5 News, Bruce St. James Radio show, Upscale magazine, and Shape.com. She was named an honoree of the 2021 Atlanta Business Chronicle's 40 under 40 award. She also is a collaborating author for the, "Made for More: Physician Entrepreneurs who Live Life and Practice Medicine on their own terms''.   Resources: FREE! Discover the 5 Reasons Your Weight-Loss Journey Has Gotten Derailed (And How To Get Back On Track!)

Send us a textIt has been a great 2025 for WDFS.  We spoke with wonderful, highly accomplished guests who provided a plethora of good advice about food science careers, about professionalism, and about life.  We welcomed Stella as our podcast editor.  We had our first Spanish/English bilingual podcast.  We were pleasantly surprised to be invited to do a live podcast at the American Society of Baking annual conference.  Incredibly (for us, anyway) the podcast is now heard in 107 countries around the world.  So much to be grateful for.In this episode we decided to interview one another about the year that was 2025.We hope you enjoy this last WDFS podcast episode of 2025 and look forward to great new interviews in 2026.Until then, keep Wolfing Down Food Science!Got a questions for us? Email us at wolfingdownfoodscience@gmail.comPlease take a minute to help others find our podcast by leaving a rating and comment on your podcasting app!

After the 2025 American Society of Hematology (ASH) Annual Meeting had passed, the  data were out, and the hematologist/oncologists of the world had time to digest the practice changes that awaited them upon their returns home. Rahul Banerjee, MD, FACP, and Brooke Adams, PharmD, BCOP, took part in an X Spaces discussion hosted by CancerNetwork® in collaboration with The American Society for Transplantation and Cellular Therapy (ASTCT) to highlight these potential changes. Adams and Banerjee discussed abstracts from the meeting, including the phase 3 MajesTEC-3 trial (NCT05083169), which evaluated teclistamab-cqyv (Tecvayli) plus daratumumab (Darzalex) in patients with relapsed/refractory multiple myeloma who progressed on at least 1 prior line of therapy.1 A significant progression-free survival benefit was observed with the experimental combination compared with standard of care in this population. They also discussed data from cohort A of the phase 2 IFM2021-01 trial (NCT05572229), which evaluated subcutaneous teclistamab in combination with subcutaneous daratumumab in patients with newly diagnosed multiple myeloma. Results demonstrated that the combination was effective and safe in the frontline treatment of patients who were ineligible for transplant.2 The discussion also covered the broader treatment landscape, as the experts compared the use of bispecific antibodies with BCMA-directed CAR T-cell therapies. Frontline bispecific strategies for transplant-ineligible populations were also topics of conversation, as well as post-transplant consolidation with bispecifics. Ultimately, they stated that multiple myeloma care is undergoing a paradigm shift toward deeper minimal residual disease negativity, possible treatment de‑escalation, and even serious use of the word “cure” for the disease. Banerjee is an assistant professor in the Clinical Research Division at the Fred Hutchinson Cancer Center, and Adams is a clinical pharmacist in the Department of Stem Cell Transplant and Cellular Therapy and coordinator of the PGY-2 Oncology Residency at Orlando Health. Both are also members of the ASTCT content committee. References Mateos M-V, Bahlis N, Perrot A, et al. Phase 3 randomized study of teclistamab plus daratumumab versus investigator's choice of daratumumab and dexamethasone with either pomalidomide or Bortezomib (DPd/DVd) in patients (Pts) with relapsed refractory multiple myeloma (RRMM): Results of majestec-3. Blood. 2025;146(suppl 2):LBA-6. doi:10.1182/blood-2025-LBA-6 Manier S, Lambert J, Marco M, et al. A phase 2 study of teclistamab in combination with daratumumab in elderly patients with newly diagnosed multiple myeloma: the IFM2021-01 teclille trial, cohort A. Blood. 2025;146(suppl 1):367. doi:10.1182/blood-2025-367

The episode features a conversation with Dr. Obed Magny, a former Sacramento police officer and co-founder of the American Society of Evidence-Based Policing. He discusses emotional intelligence and its importance in policing, including how it can help officers de-escalate tense situations by reading the room and managing their own emotions. Magny shares how he would use emotional intelligence tactics like distracting arguing parties or engaging with them in unexpected ways to diffuse domestic disputes. The discussion highlights the lack of training on soft skills like emotional intelligence compared to technical policing skills, and how developing emotional intelligence can benefit police culture and community relations.

Hello my curious archeaogastronomers!Who were the first beer makers? Why did they even made beer in the first place? Can we even find a Civilization to be the clear winner in this "race"? What's the word for beer in ancient Sumerian?What role the priests and kings plaid in this? Who even drunk beer in the ancient Mesopotamian world? All this and many more questions were buzzing through my mind.On today's episode I have as a guest the author of the book In The Land of Ninkasi: A History of Beer in Ancient Mesopotamia, Tate Paulette.Tate's book has recently won two awards:Felicia A. Holton Book Award, Archaeological Institute of AmericaThis award is given annually to a writer or writers who, through a major work of non-fiction, represents the importance and excitement of archaeology to the general public. The work should have broad public appeal and be written for an adult lay audience in a clear and engaging style. It should convey the excitement of archaeological discovery accurately and responsibly. It should be well-researched and provide new insight for the general public. https://www.archaeological.org/2026-aia-awards-spotlight-felicia-a-holton-book-award/And he also won the Nancy Lapp Popular Book Award, American Society of Overseas Research:This award is presented to the author/editor of a book published in the last two years that offers a new synthesis of archaeological or textual evidence from the Ancient Near East and Eastern Mediterranean intended to reach an audience of scholars as well as students and the broader public.https://www.asor.org/about-asor/honors-awards/previous-award-recipients/Alright! Time for my delightful and interesting I hope recommendations for this week are the following:Disco scallops:Here's a link:https://www.discoscallops.co.uk/A Spirit Never to Betray” before tequila and mescal there was another: David Lauer investigates the fate of a spiky ancient desert plant called sotol, and its alliance with generations of artisans who distil a fiery spirit from its heart.https://dark-mountain.net/a-spirit-never-to-betray/And finally the website https://www.ukrainer.netA community and organisation that has been researching Ukraine and the Ukrainian context since 2016, telling stories to Ukrainian audiences and broadcasting them to the world in dozens of languages.xEnjoy!Photo credits : Book Tate Paulette, Cuneiform Tablets Justin Kase Conder, Portrait Kathryn GrossmanThom & The Delicious LegacySupport the podcast on Ko-Fi and Patreon for ad-free episodes! https://ko-fi.com/thedeliciouslegacypodcasthttps://www.patreon.com/c/thedeliciouslegacySupport this show http://supporter.acast.com/the-delicious-legacy. Hosted on Acast. See acast.com/privacy for more information.

In episode 126, we're exploring the career and research of one of the leading scholars on gender, inequality, and crime, Professor Karen Heimer. Karen Heimer is Professor of Sociology & Criminology, Collegiate Fellow in the College of Liberal Arts & Sciences, and Distinguished Research Fellow of the Public Policy Center at the University of Iowa. She also holds a courtesy appointment in the Boyd College of Law. Heimer researches and teaches in the areas of gender and violence, juvenile delinquency, criminal punishment, and causes of crime and violence. She became a Fellow of the American Society of Criminology in 2015 and served as President of the American Society of Criminology in 2018.  She is a recipient of the 2018 Iowa Regents Award for Faculty Excellence and the 2019 UI's Hancher-Finkbine Faculty Medallion.

Christian scholar Dr. Tim Larsen joins the show to explain the real origins of the Christmas traditions we hold dear today—from Santa Claus and reindeer to ornaments and the December 25th date itself. He debunks the persistent myth that Christmas is a pagan holiday, explores how centuries of tradition shaped modern celebrations, and helps separate historical fact from popular fiction. And yes—we settle the age-old question: Is Die Hard a Christmas movie?   Dr. Timothy Larsen is a Professor of History at Wheaton College in Illinois and the president of the American Society of Church History.  His scholarly expertise is the Victorian era, the period that has done so much to shape our Christmas celebrations today, and he is an expert on Christmas.  He is the author or editor of over twenty books, including Twelve Classic Christmas Stories: A Feast of Yuletide Tales and The Oxford Handbook of Christmas.

Guests: Vicki R. Deal-Williams, ASHA's Chief Executive Officer, and Perry Flynn, 2026 ASHA President ElectEarn 0.10 ASHA CEUs for this episode with Speech Therapy PD: https://www.speechtherapypd.com/courses/the-future-of-slhThis episode is a collaboration with the Keys for SLPs podcast, hosted by Mary Beth Hines, MS, CCC-SLP. Michelle Dawson, MS, CCC-SLP, CLC, BCS-S joins as a co-host to welcome ASHA leadership Vicki R. Deal-Williams, MA, CCC-SLP, FASAE, CAE, ASHA's Chief Executive Officer, and Perry Flynn, MEd, CCC-SLP, BCS-CL, CTRI, ASHA-F, 2026 ASHA President Elect for an inside look at the evolving speech-language-hearing professions.Together, they will explore emerging technologies, workforce trends, and ongoing efforts to recruit and retain professionals, particularly those from BIPOC communities. The conversation will also highlight the SLP Interstate Compact and offer practical guidance for students and early-career professionals navigating the changing landscape of the field.About the Guests:Vicki Deal-Williams serves as the Chief Executive Officer for the American Speech-Language-Hearing Association (ASHA), where she has been a valued team member for more than three decades. A Certified Association Executive and distinguished Fellow of the American Society of Association Executives (ASAE), Vicki is also an ASHA certified speech-language pathologist and ASHA Fellow. Her expertise lies in cultivating leadership, aligning strategic goals with organizational priorities, and navigating teams through transformation with clarity and purpose. She is known for her ability to authentically build strong, collaborative relationships and to foster a welcoming culture where everyone feels they have a voice. Through clear vision, steady guidance, and deep commitment, she works alongside volunteer leaders and members, students, vendors, partners, and staff to advance ASHA's mission, achieve optimal results, and ensure lasting impact.Perry Flynn, MEd, CCC-SLP, BCS-CL, CTRI, is the Consultant to the North Carolina Department of Public Instruction in the area of Speech-Language Pathology and a Professor in the Department of Communication Sciences and Disorders at the University of North Carolina at Greensboro. He is a Fellow of the American Speech-Language-Hearing Association, a two-time member of ASHA's Board of Directors, and a Board Certified Specialist in Child Language. He is a Professional Association of Therapeutic Horsemanship (PATH) Certified Therapeutic Horseback Riding Instructor. He has presented several times at ASHA Conventions on the topic of recruiting and retaining men and minorities in speech-language pathology and has written several articles on the topic.

From Season 2 – Adaptability is an essential skill for admins and EAs. Longtime administrative professional Zynetta Canning O'Neill shares how she has navigated organizational change and why EA Ignite motivates her to rise to the challenge. Recorded at EA Ignite Fall 2023 and produced by the American Society of Administrative Professionals - ASAP. Learn more and submit a listener question at asaporg.com/podcast.

Demolition and displacement are a part of environmental injustice and the climate crisis. With that in mind, how do we remember and center the needs of the land and the wishes of the residents when it comes to decision making for public housing? Two neighbors from New York and Miami weigh in. We hope these stories empower us towards a world that centers living beings and lived experience.Episode transcript here. Narrators: Anna Williams and Renee Keitt. Additional featured audio excerpts from Razing Liberty Square (Katja Esson, 2023) and A Home Worth Fighting For (Natasha Florentino, 2025).Ms. Williams's interview is also curated in episode 25. Sources and additional reading/watching:We strongly encourage those interested in these resident campaigns to support the two documentaries at the top of the list. You can purchase a viewing pass to Razing Liberty Square or sign up for Natasha Florentino's future screenings mailing list at the links below. This support goes a long way!Katja Esson, Razing Liberty Square (2023), published by Women Make Movies, organizations can buy or book a screening at: https://www.wmm.com/catalog/film/razing-liberty-square/. Individuals can watch on PBS here: https://www.pbs.org/independentlens/documentaries/razing-liberty-square/ Natasha Florentino, A Home Worth Fighting For (2025), accessed via filmmaker. More information about future screenings at: https://www.natashaflorentino.com/ahwff. T.C. Documentaries, “Overtown, Miami (Short History of South Florida's Overtown Neighborhood),” accessed at: https://www.youtube.com/watch?v=5b6_INnChIM Digital Scholarship Lab at University of Richmond, “Renewing Inequality: Urban Renewal, Family Displacements, and Race 1950-1966,” published by American Panorama (20, ed. Robert K. Nelson and Edward L. Ayers), accessed at: https://dsl.richmond.edu/panorama/renewal/#view=0/0/1&viz=cartogram&text=definingTerry Gross, “A ‘Forgotten History' of How the U.S. Government Segregated America” (2017), published by NPR, accessed at: https://www.npr.org/2017/05/03/526655831/a-forgotten-history-of-how-the-u-s-government-segregated-america United States of America 81st Congress, “Housing Act of 1949” (1949, last amended 2024), accessed at: https://www.govinfo.gov/content/pkg/COMPS-10349/pdf/COMPS-10349.pdf T.R. Witcher, “How the interstate highway system connected—and in some cases segregated—America,” published by American Society of Civil Engineers (2021), accessed at: https://www.asce.org/publications-and-news/civil-engineering-source/civil-engineering-magazine/article/2021/07/how-the-interstate-highway-system-connected--and-in-some-cases-segregated--america Congress for the New Urbanism, “Overtown Expressway,” accessed at: https://www.cnu.org/what-we-do/build-great-places/overtown-expresswayAdam Paul Susaneck, “Segregation by Design—Miami: Overtown,” published by TU Delft Centre for the Just City (2024), accessed at: https://www.segregationbydesign.com/miami/overtown-overview New York City Housing Authority, Essence Development, Related Companies, and Housing Opportunities Unlimited, “Fulton Elliott-Chelsea Relocation Plan” (2025), accessed at: https://www.nyc.gov/assets/nycha/downloads/pdf/fec-relocation-english.pdf Damon WIlliams, Daniel Kisslinger, and People for Community Recovery, Help this Garden Grow, published by Respair Media, accessed at: https://www.respairmedia.com/help-this-garden-grow #publichousing #housingjustice #environmentaljustice #intersectionality #livedexperience #climatechange

The TML Risk Pool has seen far too many accidents and injuries in and around roadways. The Pool's goal is to provide tools to help Members avoid them, and we've developed a program to do just that. R.O.A.D. Ready (The acronym stands for Recognize the Hazards; Observe People, Processes, and Equipment; Assess the Risk Level; and Determine the Safest Course of Action) is a Risk Pool program designed to save lives, prevent injuries, and protect property by raising member awareness of dangers on and near roadways, and each January is designated as R.O.A.D. Ready month.  The program recently received national attention through publication in the June 2025 edition of Professional Safety, the American Society of Safety Professionals' flagship monthly journal, which covers the latest safety management and injury prevention trends. The article, written by Risk Pool Safety and Loss Control Consultants Kolby Burkhart and Manny Trejo, is titled “Improving Roadways Safety: A Practical Framework to Protect Frontline Workers.” Check out the article here and listen to this episode to hear Kolby and Manny discuss ways to keep your city R.O.A.D. Ready! The Pool extends special recognition to the following R.O.A.D. Ready month participating Members: the Lower Valley Water District and the Cities of Anthony, Mont Belvieu, Beeville, Liberty Hill, Port Neches, Nederland, Rockport, Ingleside, Portland, Jasper, Livingston, Frisco, Schertz, and Fredericksburg. FURTHER INFORMATION:R.O.A.D. Ready Web PageFind Your Safety and Loss Control ConsultantSafety @ Your Fingertips Sign UpProfessional Safety Article2024-2025 Year in Review T.I.P.S. SheetTexas Police Chiefs Association VINCIBLE Training Programlawenforcementoutreach@tmlirp.orgJanuary R.O.A.D. Ready Risk Pool Trainings:January 6 Frisco Trenching and Excavation Awareness (1:00 p.m. - 3:00 p.m.) January 13 LVWD/Clint Loading and Transporting of Equipment (8:30 a.m. - 11:30 a.m.) Field Operations Safety (1:30 p.m. - 3:30 p.m.) January 13 & 27 Schertz Safe Police Vehicle Operations (8:30 a.m. - 11:30 a.m., 1:00 p.m. - 4:00 p.m.) January 14 Anthony Trenching and Excavation Awareness (8:00 a.m. - 10:00 a.m.) Work Zone Safety (10:15 a.m. - 12:15 p.m.) Field Operations Safety (1:30 p.m. - 3:30 p.m.) January 20-21 Fredericksburg Safe Police Vehicle Operations (1:30 p.m. - 4:30 p.m., 8:30 a.m. - 11:30 a.m.

I almost can't believe that we are wrapping up yet another year on the podcast this month, which has been going strong for 6 years now! And it has been another exciting year in the world of Clin Micro as well with improvements and new assays available for some of our bread and butter tests, but the year also brought about significant developments in the application of AI and digital imaging, use of NGS methods, and probably some cool AST stuff in there too among other things, with many of these advancements published in JCM. And so, as has become customary for the last 6 years, for this episode, we will be sharing some of our favorite papers or more intriguing manuscripts published in the Journal this year. And I have to say, this is probably one of the hardest episodes to prep for because picking just on paper to talk about is an incredible difficult task! But, we are up to the challenge and we'll share those with you over the next half hour or so, all the while wearing ridiculous holiday sweaters and/or holiday headgear, as is now tradition. So, if you are not watching, you may want to switch and find a video option for your viewing pleasure.  Watch this episode: https://youtu.be/taqcjqeQQBE Paper Links: Interlaboratory assays from the fungal PCR Initiative and the Modimucor Study Group to improve qPCR detection of Mucorales DNA in serum: one more step toward standardization | Journal of Clinical Microbiology https://journals.asm.org/doi/10.1128/jcm.01525-24 Detection of protozoan and helminth parasites in concentrated wet mounts of stool using a deep convolutional neural network | Journal of Clinical Microbiology https://journals.asm.org/doi/10.1128/jcm.01062-25 Prediction of antimicrobial susceptibility of pneumococci based on whole-genome sequencing data: a direct comparison of two genomic tools to conventional antimicrobial susceptibility testing | Journal of Clinical Microbiology https://journals.asm.org/doi/10.1128/jcm.01079-24      a. Bonus: Rapid detection of gram-negative antimicrobial resistance determinants directly from positive blood culture broths using a multiplex PCR system | Journal of Clinical Microbiology https://journals.asm.org/doi/10.1128/jcm.00384-25 A novel single-tier serologic test to diagnose all stages of Lyme disease | Journal of Clinical Microbiology https://journals.asm.org/doi/10.1128/jcm.00483-25 This episode of Editors in Conversation is brought to you by the Journal of Clinical Microbiology and hosted by JCM Editor in Chief, Romney Humphries, Ph.D., D(ABMM) and Elitza (Elli) Theel, Ph.D., D(ABMM).  Editors in conversation is supported by the American Society for Microbiology, which publishes JCM. Become an ASM member to receive up to 50% off publishing fees when you publish in JCM or any of the ASM journals.  Sign up at https://asm.org/joinasm. Visit https://journals.asm.org/journal/jcm to read articles and/or submit a manuscript. Get the audio only podcast at https://asm.org/eic.

"Within-family genomic selection in strawberry: optimization of marker density, trial design, and training set composition" with Dr. Joshua Sleper If plant breeding were a poker game, you'd have to play a lot of hands to beat the house. Quantitative genetics hopes to give players an advantage by recognizing patterns that can point to future success. In strawberry, a genetically complex and labor-intensive plant, this is particularly important. This episode, Joshua join me to discuss his work using quantitative genetics to help give strawberry breeders a hand. Tune in to learn: ·        How some plants have "sticky cards" in their genetics ·        What challenges strawberry breeders face ·        How many clones are really enough ·        What lies on the horizon for strawberry breeding If you would like more information about this topic, this episode's paper is available here: https://doi.org/10.1002/tpg2.20550 This paper is always freely available. Contact us at podcast@sciencesocieties.org or on Twitter @FieldLabEarth if you have comments, questions, or suggestions for show topics, and if you want more content like this don't forget to subscribe. If you'd like to see old episodes or sign up for our newsletter, you can do so here: https://fieldlabearth.libsyn.com/. If you would like to reach out to Joshua, you can find him here: j.sleper@ufl.edu Resources CEU Quiz: https://web.sciencesocieties.org/Learning-Center/Courses/Course-Detail?productid=%7b9908BAD4-89DB-F011-8544-000D3A3685DF%7d  Transcripts: Coming soon Rex Bernardo's Essentials of Plant Breeding: https://www.abebooks.com/9780972072427/Essentials-Plant-Breeding-Rex-Bernardo-097207242X/plp   A Quarter Century of Genomewide Prediction - Dr. Rex Bernardo: https://www.youtube.com/watch?v=K45M4N9mJBM&t=8s Field, Lab, Earth is Copyrighted by the American Society of Agronomy, Crop Science Society of America, and Soil Science Society of America.

My conversation with Dr Emanuel begins at about 34 minutes Subscribe and Watch Interviews LIVE : On YOUTUBE.com/StandUpWithPete ON SubstackStandUpWithPete Stand Up is a daily podcast. I book,host,edit, post and promote new episodes with brilliant guests every day. This show is Ad free and fully supported by listeners like you! Please subscribe now for as little as 5$ and gain access to a community of over 750 awesome, curious, kind, funny, brilliant, generous soul In Eat Your Ice Cream, renowned health expert Dr. Ezekiel J. Emanuel argues that life is not a competition to live the longest, and that "wellness" shouldn't be difficult; it should be an invisible part of one's lifestyle that yields maximum health benefits with the least work Ezekiel J. Emanuel, MD, PhD, is the Vice Provost for Global Initiatives, the Co-Director of the Healthcare Transformation Institute, and the Diane v.S. Levy and Robert M. Levy University Professor at the University of Pennsylvania Perelman School of Medicine. Emanuel is an oncologist and world leader in health policy and bioethics. He is a Special Advisor to the Director General of the World Health Organization, Senior Fellow at the Center for American Progress, and member of the Council on Foreign Relations.  He was the founding chair of the Department of Bioethics at the National Institutes of Health and held that position until August of 2011. From 2009 to 2011, he served as a Special Advisor on Health Policy to the Director of the Office of Management and Budget and National Economic Council. In this role, he was instrumental in drafting the Affordable Care Act (ACA). Emanuel also served on the Biden-Harris Transition Covid Advisory Board. Dr. Emanuel is the most widely cited bioethicist in history.  He has over 350 publications and has authored or edited 15 books. His recent publications include the books Which Country Has the World's Best Health Care (2020), Prescription for the Future (2017), Reinventing American Health Care: How the Affordable Care Act Will Improve our Terribly Complex, Blatantly Unjust, Outrageously Expensive, Grossly Inefficient, Error Prone System (2014) and Brothers Emanuel: A Memoir of an American Family (2013). In 2008, he published Healthcare, Guaranteed: A Simple, Secure Solution for America, which included his own recommendations for health care reform. Dr. Emanuel regularly contributes to the New York Times, the Washington Post, the Wall Street Journal, The Atlantic, and often appears on BBC, NPR, CNN, MSNBC and other media outlets. He has received numerous awards including election to the National Academy of Medicine, the American Academy of Arts and Sciences, the Association of American Physicians, and the Royal College of Medicine (UK). He has been named a Dan David Prize Laureate in Bioethics, and is a recipient of the AMA-Burroughs Wellcome Leadership Award, the Public Service Award from the American Society of Clinical Oncology, Lifetime Achievement Award from the American Society of Bioethics and Humanities, the Robert Wood Johnson Foundation David E. Rogers Award, President's Medal for Social Justice Roosevelt University, and the John Mendelsohn Award from the MD Anderson Cancer Center. Dr. Emanuel has received honorary degrees from Icahn School of Medicine at Mount Sinai, Union Graduate College, the Medical College of Wisconsin, and Macalester College. In 2023, he became a Guggenheim Fellow. Dr. Emanuel is a graduate of Amherst College. He holds a M.Sc. from Oxford University in Biochemistry, and received his M.D. from Harvard Medical School and his Ph.D. in political philosophy from Harvard University. On YOUTUBE.com/StandUpWithPete ON SubstackStandUpWithPete   Listen rate and review on Apple Podcasts Listen rate and review on Spotify Pete On Instagram Pete on Blue Sky Pete on Threads Pete on Tik Tok Pete on Twitter Pete Personal FB page Stand Up with Pete FB page All things Jon Carroll  Gift a Subscription https://www.patreon.com/PeteDominick/gift Send Pete $ Directly on Venmo  

Melanie Dodd, PharmD, PhC, BCPS, FASHP, is the current President of the American Society of Health-System Pharmacists (ASHP) and the Associate Dean for Clinical Affairs and Professor at the University of New Mexico College of Pharmacy. Dr. Dodd talks through her priorities for ASHP this year, her involvement in the progressive New Mexico Society of Health-System Pharmacists, and her advice to those looking to get involved!

 Fertility Docs Uncensored is hosted by Dr. Carrie Bedient from the Fertility Center of Las Vegas, Dr. Susan Hudson from Texas Fertility Center, and Dr. Abby Eblen from Nashville Fertility Center. In this episode, the docs welcome visiting physician Dr. Shelley Dolitsky from Shady Grove Fertility in Towson, Maryland, for an in-depth conversation about recurrent pregnancy loss. Dr. Dolitsky begins by reviewing how different professional organizations define recurrent pregnancy loss. The American Society for Reproductive Medicine considers two or more losses—including very early biochemical losses—to be recurrent pregnancy loss, while the American College of OB/GYN defines it as two clinical losses under 20 weeks. The docs discuss how age dramatically affects miscarriage risk, with up to 75% of women over 40 experiencing miscarriages, compared with an overall rate of three to five percent. They walk through the full evaluation, which includes assessing the uterine cavity for abnormalities such as scar tissue, polyps, or congenital malformations; ensuring the fallopian tubes are normal and ruling out tubal damage; and performing chromosome analysis on both partners. Testing for antiphospholipid antibodies and lupus anticoagulant is also essential, as these can contribute to placental clotting issues. The conversation highlights the importance of screening for chronic medical issues that might be undiagnosed. About half of patients with recurrent pregnancy loss will have an identifiable and often treatable cause. Finally, the team discusses recommendations for patients whose workup is normal but who continue to experience losses. This podcast was sponsored by Shady Grove Fertility. 

From Season 2 – Do you struggle with work-life balance? Executive and personal assistant Ike Saunders shares how to delineate boundaries and thrive in a role that blends the personal and professional. Recorded at EA Ignite Fall 2023 and produced by the American Society of Administrative Professionals - ASAP. Learn more and submit a listener question at asaporg.com/podcast.

The Cognitive Crucible is a forum that presents different perspectives and emerging thought leadership related to the information environment. The opinions expressed by guests are their own, and do not necessarily reflect the views of or endorsement by the Information Professionals Association. During this episode, Michael Lissack discusses Anticipatory Agents in Causal Bubbles–a unified theoretical framework that reconciles Quantum Bayesianism (QBism), Robert Rosen's theory of Anticipatory Systems, the causal bubbles interpretation of quantum mechanics, and pragmatic constructivism through Hans Vaihinger's philosophy of 'as if.' Recording Date: 2 Dec 2025 Research Question: Michael Lissack suggests an interested student or researcher examine how can the continuous process of asking "what gives this symbol, sign, or phrase meaning?" (synecdoche) against the background of the "information abyss" lead to a developed sense of understanding? Resources: Cognitive Crucible Podcast Episodes Mentioned #7 Randy Rosin on Russia and Applied Cybernetics #72 Noah Komnick on Cybernetics and the Age of Complexity #47 Yaneer Bar-Yam on Complex Systems and the War on Ideals #85 Josh Kerbel on Complexity and Anticipatory Intelligence Anticipatoryagents.com Anticipatory Agents in Causal Bubbles: Reconciling Quantum Bayesianism, Rosen's Anticipatory Systems, and Pragmatic Constructivism by Michael Lissack WHAT SCIENTIFIC TERM OR CONCEPT OUGHT TO BE MORE WIDELY KNOWN? Ashby's Law of Requisite Variety by John Naughton Destruction and Creation by John Boyd (1976) W. R. Ashby, "Requisite variety and its implications for the control of complex systems," Cybernetica, vol. 1, no. 2, pp. 83–99, 1958. Link to full show notes and resources Guest Bio: Michael Lissack, the founder and director of the Second Order Science Foundation, has dedicated his academic career to understanding how individuals and organizations can learn and adapt in a rapidly changing world. Lissack's work focuses on the intersection of cognition, communication, and technology, and he has developed innovative approaches to knowledge management, organizational learning, and leadership development. Lissack was the president of American Society for Cybernetics, founder of the Institute for the Study of Coherence and Emergence, and founding editor of the journal Emergence.  He has taught at several universities throughout the world, including Erasmus in the Netherlands and Tongji in Shanghai.  He holds a D.B.A. in complex systems from Brunel University and Henley Management College. About: The Information Professionals Association (IPA) is a non-profit organization dedicated to exploring the role of information activities, such as influence and cognitive security, within the national security sector and helping to bridge the divide between operations and research. Its goal is to increase interdisciplinary collaboration between scholars and practitioners and policymakers with an interest in this domain. For more information, please contact us at communications@information-professionals.org. Or, connect directly with The Cognitive Crucible podcast host, John Bicknell, on LinkedIn. Disclosure: As an Amazon Associate, 1) IPA earns from qualifying purchases, 2) IPA gets commissions for purchases made through links in this post.

Matters Microbial #118: Biofilms Everywhere! December 15, 2025 Today Dr. Matthew Fields, Director of the Center for Biofilm Engineering at Montana State University, joins the #QualityQuorum to discuss ubiquitous microbial biofilms. These biofilms touch so many aspects of life on Earth, ranging from human health to engineering issues!   Host: Mark O. Martin Guest: Matthew Fields Subscribe: Apple Podcasts, Spotify Become a patron of Matters Microbial! Links for this episode The website for the American Society for Microbiology's Conference for Undergraduate Educators.  Highly recommended! The must-read story of Angelina Hesse, and the first use of agar to solidify microbiological media.  Here is a Kickstarter project involving promoting this important piece of microbiological history.  And here is a video made by former podcast guest Dave Westenberg on the Hesse agar story. An engaging video for budding #Micronauts explaining the general concept of quorum sensing in bacteria. A video overview of biofilms on Earth.  Perhaps we should call Earth "Planet Biofilm"! Here is an older review of biofilms that is very easy to read and fun to think about. Here is a newer review of the impact that biofilms can have in health, agriculture, industry, and ecology.   A video interview with the late "father" of biofilm research, William J. Costerton. The concept that stromatolites are fossilized biofilms.  A video describing the biofilm "life cycle." Recent developments in the details of how biofilms form. An article on biofilms and evolution of multicellularity. Previous podcast guest Dr. Vaughn Cooper's "Evolving STEM" outreach project that places biofilms front and center. The challenge of antibiotic resistance and biofilms. The website of the Center for Biofilm Engineering at Montana State University.  There is so much to see here, at every level.  It is a grand resource for anyone interested in biofilms. The Center for Biofilm Engineers "fact page" on biofilms. Dr. Fields' research page, where you can find information about the kinds of projects discussed today. An engaging video from Dr. Fields institution on biofilms. Dr. Fields' faculty page. Intro music is by Reber Clark Send your questions and comments to mattersmicrobial@gmail.com

Host: Ryan Quigley Guest: Kathrin M. Bernt, MD Guest: Rushabh Mehta, BS Guest: Fatemeh Alikarami New data presented at the American Society of Hematology (ASH) Annual Meeting and Exposition reveals how chemotherapy and immunotherapy may drive the emergence of CD-19–negative, myeloid-like subclones in pediatric B-cell acute lymphoblastic leukemia (B-ALL). Mr. Ryan Quigley sits down with Dr. Kathrin Bernt, Dr. Fatemah Alikarami, and Mr. Rushabh Mehta to discuss how their findings could impact minimal residual disease detection, therapy resistance, and future risk stratification strategies. Dr. Bernt is a pediatric oncologist and an Associate Professor of Pediatrics at the Children's Hospital of Philadelphia. Dr. Alikarami is a Research Associate Scientist at the Children's Hospital of Philadelphia. Mr. Mehta is a PhD candidate in cell and molecular biology at the University of Pennsylvania.

Audio roundup of selected biopharma industry content from Scrip over the business week ended December 12, 2025. This week, a focus on five key results from the American Society of Hematology (ASH) meeting – Jaypirca headed for the front line; Kite's Anito-cel in multiple myeloma; next-generation CAR-T approaches; Kelownia's early in vivo CAR-T data; and Novartis's ianalumab's potential in ITP. Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-RFOOY2665REEZEN5SMJ2GW27EY/ This episode was produced with the help of AI text-to-voice and voice emulation tools. Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things

At the 2025 American Society of Hematology Annual Meeting & Exposition (ASH), CancerNetwork® sat down with a variety of researchers and clinicians to discuss potential advancements across hematologic oncology care. These experts shared their findings related to investigational therapeutic regimens and strategies that may prove impactful across different multiple myeloma, lymphoma, and leukemia populations. First, Krina K. Patel, MD, MSc, highlighted findings from the phase 2 iMMagine-1 study (NCT05396885) assessing treatment with anitocabtagene autoleucel (anito-cel) among patients with relapsed/refractory multiple myeloma. According to Patel, an associate professor in the Department of Lymphoma/Myeloma in the Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center in Houston, Texas, the novel cellular therapy elicited an overall response rate (ORR) of 96% and a stringent complete response or CR rate of 74% among the evaluable patients. She also discussed how anito-cel's unique mechanism of action may show efficiency compared with other cellular therapy products while reducing the risk of cytokine release syndrome and other delayed toxicities. Next, Manali Kamdar, MD, spoke about data from a long-term follow-up phase 2/3 study (NCT03435796) based on the phase 3 TRANSFORM trial (NCT03575351) evaluating lisocabtagene maraleucel (liso-cel; Breyanzi) vs standard-of-care therapy for patients with relapsed/refractory large B-cell lymphoma (LBCL). Long-term follow-up showed that liso-cel continued to elicit improvements in progression-free survival and overall survival across this population. Kamdar, the clinical director of Lymphoma Services at the University of Colorado Anschutz School of Medicine, touched upon the patient subpopulations who are most suitable to receive liso-cel while emphasizing the agent's curative potential in the second-line setting. Finally, Wei Ying Jen, BM BCh, MA, MMed, MRCP, FRCPath, detailed results from the phase 1/2 SAVE trial (NCT05360160), which showed responses with an all-oral combination of revumenib (Revuforj), decitabine/cedazuridine (Inqovi), and venetoclax (Venclexta) for patients with newly diagnosed acute myeloid leukemia. Jen, an assistant professor in the Department of Leukemia in the Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center in Houston, Texas, noted how an all-oral regimen may offer an “advantage” compared with standard intensive chemotherapy, which requires patients to travel to the hospital to undergo an infusion. References Patel K, Dhakal B, Kaur G, et al. Phase 2 registrational study of anitocabtagene autoleucel for the treatment of patients with relapsed and/or refractory multiple myeloma: updated results from iMMagine-1. Blood. 2025;146(suppl 1):256. doi:10.1182/blood-2025-256 Kamdar M, Solomon S, Arnason J, et al. Lisocabtagene maraleucel (liso-cel) versus standard of care (SOC) for second-line relapsed or refractory large B-cell lymphoma (LBCL): First Results from long-term follow-up of TRANSFORM. Blood. 2025;146(suppl 1):3710. doi.10.1182/blood-2025-3710 Jen WY, DiNardo CD, Short NJ, et al. Phase II study of the all-oral combination of revumenib (SNDX-5613) with decitabine/cedazuridine (ASTX727) and venetoclax (SAVE) in newly diagnosed AML. Blood. 2025;146(suppl 1):47. doi:10.1182/blood-2025-47

In this episode of the DermSurgery Digest, you'll hear a summary of the cosmetic and general dermatology articles in the December 2025 issue of Dermatologic Surgery followed by commentary from special guest contributors Hooman Khorasani, MD, and Payvand Kamrani, DO. This podcast is hosted by Dermatologic Surgery Digital Content Editor, Naomi Lawrence, MD, and co-hosted by Michael Renzi, MD. Dermatologic Surgery is the official publication of the American Society for Dermatologic Surgery. In this podcast series the surgical oncology and reconstruction articles in the December issue of Dermatologic Surgery are featured in a separate episode. Your feedback is encouraged. Please contact communicationstaff@asds.net. 

In this episode of the DermSurgery Digest, you'll hear a summary of the surgical oncology and reconstruction articles in the December 2025 issue of Dermatologic Surgery followed by commentary from special guest contributors Marc Brown, MD, and Kyle Lauck, MD. This podcast is hosted by Dermatologic Surgery Digital Content Editor, Naomi Lawrence, MD, and co-hosted by Michael Renzi, MD. Dermatologic Surgery is the official publication of the American Society for Dermatologic Surgery. In this podcast series the cosmetic and general dermatology articles in the December issue of Dermatologic Surgery are featured in a separate episode. Your feedback is encouraged. Please contact communicationstaff@asds.net 

Stu Burguiere reacts to Time naming the “Architects of AI” as the magazine's person of the year and looks at a few breaking AI stories to determine if we're heading toward a utopian future or certain disaster. Then, the Crime Prevention Research Center's John R. Lott Jr. joins to discuss how current gun control policies are failing minority communities who need the protection the most. And Stu has the latest updates on Glenn Beck's attempts to bring a Canadian woman to America for a lifesaving surgery. TODAY'S SPONSORS   AMERICAN GIANT CLOTHING Buy American today at http://www.american-giant.com/STU and save 20% when you use the name ‘STU' at checkout   REAL ESTATE AGENTS I TRUST For more information, please visit http://www.realestateagentsitrust.com Learn more about your ad choices. Visit megaphone.fm/adchoices

Nick Fuentes says we need "order before liberty," admires Stalin, and wants a government strongman to re-industrialize America. We break down why that worldview is dangerous and why the housing crisis is NOT a free market failure. In this episode of Good Morning Liberty, Nate and Chuck dive into: Why 2025 home prices feel insane (and what's actually changed since the 1950s) How building codes, zoning, the Fed, and regulations drive prices up Nick Fuentes' claim that liberty isn't the highest political virtue His "Stalin admirer" comments and calls for tariffs, subsidies, and a strongman Why empires, industrial policy, and libertarianism don't mix

This bonus episode of DermSurgery Digest features interviews recorded live at the 2025 ASDS Annual Meeting to provide the top pearls, insights and takeaways from the premier dermatologic surgery meeting of the year, held in Chicago, IL, on Nov. 13-16, 2025. The cosmetic dermatologic surgery sessions discussed, and the contributors featured are: Integrating Cosmetic Surgery into Your Practice featuring Drs. Shawn Allen and Kyle LauckFat Grafting: New Discoveries and New Techniques featuring Drs. Lisa Donofrio and Megan McCleanASDS Glam Slam featuring Drs. Jamie Hu and Kyle LauckGLP-1: From Prescribing to Managing Volume Loss featuring Drs. Kavita Mariwalla and Sydney ProfferLower Face Cosmesis featuring Drs. Jean Carruthers and Ardalan MinokadehMaking the Most of Your Laser Settings featuring Drs. Paul Friedman and Pooja RambhiaNeuromodulators – The Cutting Edge featuring Drs. Deirdre Hooper, Rachel Pritzker and Sydney ProfferASDS Cosmetics Oral Abstract featuring Drs. Kyle Lauck, Aman Nihal and Nathalia Simonetti This podcast is hosted by Dermatologic Surgery Digital Content Editor, Naomi Lawrence, MD, and co-hosted by Michael Renzi, MD. Dermatologic Surgery is the official publication of the American Society for Dermatologic Surgery.Practice management, surgical oncology and reconstruction sessions are featured in a separate episode. Your feedback is encouraged. Please contact communicationstaff@asds.net.

This bonus episode of DermSurgery Digest features interviews recorded live at the 2025 ASDS Annual Meeting to provide the top pearls, insights and takeaways from the premier dermatologic surgery meeting of the year, held in Chicago, IL, on Nov. 13-16, 2025. The practice management, surgical oncology and reconstruction sessions discussed, and the contributors featured are: Knots and Bots: Dermatologic Surgery in the Era of AI featuring Drs. Daniel Schlessinger and Kyle LauckBeyond the Textbook: Controversies in Cutaneous Oncology and Dermatologic Surgery featuring Drs. Jordan Lim, David Carr and Kathryn ShahwanUnlocking the Job Search: Tips for Residents and Early Career Physicians featuring Drs. Mona Sadeghpour and Yssra SolimanSkin Substitute Alternatives for Recalcitrant Postoperative Wounds featuring Drs. Tara Jennings and Ally-Khan SomaniAdvanced Reconstruction featuring Drs. Tara Jennings and Naomi Lawrence This podcast is hosted by Dermatologic Surgery Digital Content Editor, Naomi Lawrence, MD, and co-hosted by Michael Renzi, MD. Dermatologic Surgery is the official publication of the American Society for Dermatologic Surgery.Cosmetic dermatologic surgery sessions are featured in a separate episode. Your feedback is encouraged. Please contact communicationstaff@asds.net.

There is a demographic shift hiding in plain sight. In a few short years, the United States will have more people over 60 than children under 18. For Leanne Clark-Shirley, that statistic is not a curiosity for actuaries. It is “the mega trend of our moment” and a direct test of how leaders think about work, culture and contribution. Leanne is the President and CEO of the American Society on Aging, a seventy-one-year-old professional home for everyone who cares about aging, from community nutrition sites and academics to tech startups and interior designers. She is a social gerontologist who has spent more than two decades in aging-related nonprofit, consulting and academic roles, including senior work at AARP and in policy research and evaluation. In this episode of Leadership NOW, we discuss: • why executives continue to treat aging as a backstage topic about benefits and pensions • how language, especially words like “elderly”, quietly swindles older workers out of opportunity • the evidence that older entrepreneurs and older workers are powerful sources of innovation and stability • the practical moves leaders can make to design “with, not for” across ages • two simple experiments Leanne recommends to change how you notice age in your own life and organization Leanne also shares ASA's North Star, captured in her line that “longevity is the goal, and aging is how we get there”, and what it means for leaders who want their organizations to thrive in the longevity era. Find out more: American Society on Aging: https://www.asaging.org Dan Pontefract: www.danpontefract.com

Read the full show notes: https://www.draimee.org/from-patient-connection-to-policy-change-advancing-fertility-amp-ivf-care-in-the-u-s-with-guest-kaylen-silverberg-md In this episode of The Egg Whisperer Show, I'm thrilled to welcome Dr. Kaylen Silverberg, medical director and managing partner at Texas Fertility Center, co-founder of Ovation Fertility, and a leading advocate for patients navigating IVF and reproductive medicine in the United States. Dr. Silverberg shares his journey from aspiring heart surgeon to passionate fertility specialist, and how his deep connections with patients inspired him to bridge the gap between clinical care and national policy change. Watch this episode on YouTube. In this episode, we cover: Dr. Silverberg's personal journey from heart surgery to reproductive medicine The power of patient stories in influencing national policy and lawmakers The mission and current legislative efforts of Americans for IVF Recent changes and proposals to make fertility medications and IVF more affordable The impact of bipartisan advocacy and the importance of building relationships with representatives Advances in endometriosis research and its effect on fertility The promise and limitations of genetic testing in IVF How listeners can get involved in advocacy and make their voices heard Resources: Texas Fertility Center: https://www.txfertility.com Americans for IVF: https://americansforivf.org Resolve: The National Infertility Association: https://resolve.org American Society for Reproductive Medicine: https://asrm.org Dr. Silverberg's Instagram: https://www.instagram.com/lets_talk_about_fertility/ Subscribe to The Egg Whisperer Show on YouTube and Spotify Join Dr. Aimee's IVF Class at The Egg Whisperer School Learn About Dr. Aimee's Fertility Essentials

Doctor Mau Informa ®️#drmauinforma 

From Season 2 – Want to be seen as a capable, confident leader? Alicia Fairclough, founder of EA How To, shares ways you can exude executive energy and prove your value as a strategic business partner. Recorded at EA Ignite Fall 2023 and produced by the American Society of Administrative Professionals - ASAP. Learn more and submit a listener question at asaporg.com/podcast.

The Author Events Series presents Miriam Toews | A Truce That Is Not Peace In Conversation with Katy Waldman ''Why do you write?'' the organizer of a literary event in Mexico City asks Miriam Toews. Each attempted answer from Toews-all of them unsatisfactory to the organizer-surfaces new layers of grief, guilt, and futility connected to her sister's suicide. She has been keeping up, she realizes, a decades-old internal correspondence, filling a silence she barely understands. And we, her readers, come to see that the question is as impossible to answer as deciding whether to live life as a comedy or a tragedy. Marking the first time Toews has written her own life in nonfiction, A Truce That Is Not Peace explores the uneasy pact a writer makes with memory. Wildly inventive yet masterfully controlled; slyly casual yet momentous; wrenching and joyful; hilarious and humane-this is Miriam Toews at her dazzling best, remaking her world and inventing an astonishing new literary form to contain it. Miriam Toews is the author of the bestselling novels Women Talking, Fight Night, All My Puny Sorrows, Summer of My Amazing Luck, A Boy of Good Breeding, A Complicated Kindness, The Flying Troutmans, and Irma Voth, and two works of nonfiction, A Truce That is Not Peace and Swing Low: A Life. She is winner of the Governor General's Award for Fiction, the Libris Award for Fiction Book of the Year, the Rogers Writers' Trust Fiction Prize, and the Writers' Trust Engel/Findley Award. She lives in Toronto. Katy Waldman is a staff writer at The New Yorker, for which she writes about books, culture, and more. Previously, she was a staff writer at Slate and the host of the ''Slate's Audio Book Club'' podcast. She won the National Book Critics Circle's Nona Balakian Citation for Excellence in Reviewing in 2019 and the American Society of Magazine Editors's award for journalists under thirty in 2018; her work has appeared in The New York Times, The Washington Post, New York magazine, the Paris Review, and elsewhere. She lives with her husband and dog in Washington, D.C. Because you love Author Events, please make a donation when you register for this event to ensure that this series continues to inspire Philadelphians. Books will be available for purchase at the library on event night! All tickets are non-refundable. (recorded 9/3/2025)

Fueled by cancer, obesity and cardiovascular deals, $1 billion-plus takeouts in biotech are at their highest level in a decade with three weeks to go in the year. On the latest BioCentury This Week, BioCentury's analysts discuss the rise in large M&A deals and what the trends among the 37 acquisitions say about biopharma dealmaking.The analysts assess first-in-human in vivo CAR T data at the American Society of Hematology meeting from Kelonia Therapeutics, which showcase the promise of the modality and justify the growing pipeline. They also break down readouts from Praxis in developmental and epileptic encephalopathy from the American Epilepsy Society Annual Meeting and from Novo Nordisk, which presented full data at the Clinical Trials on Alzheimer's Disease meeting on semaglutide's failure to treat Alzheimer's disease.Washington Editor Steve Usdin analyzes a roller-coaster week at FDA in which Richard Pazdur resigned as director of FDA's Center for Drug Evaluation and Research and Tracy Beth Høeg became acting CDER director, a move that Usdin says will prompt staff departures, ease restraints on FDA leadersView full story: https://www.biocentury.com/article/657781#BiotechMA #CARTTherapy #EpilepsyResearch #AlzheimersDisease #FDA02:37 - Biotech M&A06:39 - In vivo CAR T10:08 - Semaglutide for Alzheimer's16:17 - Praxis22:11 - FDATo submit a question to BioCentury's editors, email the BioCentury This Week team at podcasts@biocentury.com.Reach us by sending a text

Equitable access to treatment is vital for older adults with Alzheimer's and other neurodegenerative diseases, especially in long-term care. CMS's Long-Stay Antipsychotic Medication quality measure aimed to curb inappropriate use in nursing homes, but it has also led to unintended consequences, limiting safe, effective treatment options for more than 3 million residents.A new Manatt Health report, supported by the Alliance's Project PAUSE Coalition, explores these impacts and offers recommendations to restore equitable care. Joining us to discuss the findings are Chad Worz, CEO of the American Society of Consultant Pharmacists and Project PAUSE convener, and geriatric psychiatrist Dr. Amita Patel.

Enid Martinez, MD is a Senior Associate in Critical Care at Boston Children's Hospital, and an Assistant Professor of Anaesthesia at Harvard Medical School. She is the Director of the Pediatric Critical Care Nutrition Program in the Division of Critical Care Medicine and Principal Investigator for a clinical-translational research program on gastrointestinal function and nutrition in pediatric critical illness.Learning Objectives:By the end of this podcast, listeners should be able to:Recognize the impact of nutritional status on outcomes of critically-ill children.Describe the key aspects of the metabolic stress response in critical illness.Discuss a clinical approach to accurately estimating and prescribing nutrition in critically-ill children.Reflect on an expert's approach to managing aspects of nutrition in critically-ill children where there may not be high-quality evidence. Selected references:Mehta et al. Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Pediatric Critically Ill Patient: Society of Critical Care Medicine and American Society for Parenteral and Enteral Nutrition. JPEN J Parenter Enteral Nutr. 2017 Jul;41(5):706-742. doi: 10.1177/0148607117711387. Epub 2017 Jun 2. PMID: 28686844. Fivez et al. Early versus Late Parenteral Nutrition in Critically Ill Children. N Engl J Med. 2016 Mar 24;374(12):1111-22. doi: 10.1056/NEJMoa1514762. Epub 2016 Mar 15. PMID: 26975590.Questions, comments or feedback? Please send us a message at this link (leave email address if you would like us to relpy) Thanks! -Alice & ZacSupport the showHow to support PedsCrit:Please complete our Listener Feedback SurveyPlease rate and review on Spotify and Apple Podcasts!Donations are appreciated @PedsCrit on Venmo , you can also support us by becoming a patron on Patreon. 100% of funds go to supporting the show. Please remember that all content during this episode is intended for educational and entertainment purposes only. It should not be used as medical advice. The views expressed during this episode by hosts and our guests are their own and do not reflect the official position of their institutions. If you have any comments, suggestions, or feedback-you can email us at pedscritpodcast@gmail.com. You can also check out our website at http://www.pedscrit.com. Thank you for listening to this episode of PedsCrit!

If you're over 60 and using GLP-1 medications like Wegovy or Zepbound, this episode could save your independence. In this episode, I reveal the hidden danger of rapid weight loss without muscle protection—and the simple strategies that keep you strong, steady, and mobile as the pounds come off. GLP-1 medications are transforming weight loss for older adults managing diabetes, high blood pressure, and joint pain. But there's a critical piece most people miss: sarcopenia. This age-related muscle loss accelerates during weight loss, putting you at risk for falls, fractures, and losing the strength you need for daily activities. Tune in to learn how to lose weight safely while protecting the muscle that keeps you independent—and why strength training, protein intake, and staying active aren't optional on this journey.   Episode Highlights: Why GLP-1 medications like Wegovy and Zepbound are game-changers for adults 60+ The connection between muscle loss, falls, fractures, and loss of independence How sarcopenia affects metabolism, blood sugar control, and bone health Protein requirements for older adults (25-30 grams per meal) Simple strength training routines you can do at home—no gym required Red flags that muscle loss is happening too fast Real patient story: turning weakness into strength on a GLP-1 journey   Connect with Dr. Alicia Shelly: Website | drshellymd.com Facebook | www.facebook.com/drshellymd Instagram | @drshellymd Linked In | www.linkedin.com/in/drshellymd Twitter | @drshellymd   About Dr. Alicia Shelly Dr. Alicia Shelly was raised in Atlanta, GA. She received her Doctorate of Medicine from Case Western Reserve University School of Medicine in Cleveland, OH.  Dr. Shelly has been practicing Primary Care and Obesity medicine since 2014.  In 2017, she became a Diplomat of the American Board of Obesity Medicine. She is the lead physician at the Wellstar Medical Center Douglasville. She started a weekly podcast & Youtube channel entitled Back on Track: Achieving Healthy Weight loss,  where she discusses how to get on track and stay on track with your weight loss journey. She has spoken for numerous local and national organizations, including the Obesity Medicine Association, and the Georgia Chapter of the American Society of Metabolic and Bariatric Surgeons. She has been featured on CNN, Fox 5 News, Bruce St. James Radio show, Upscale magazine, and Shape.com. She was named an honoree of the 2021 Atlanta Business Chronicle's 40 under 40 award. She also is a collaborating author for the, "Made for More: Physician Entrepreneurs who Live Life and Practice Medicine on their own terms''.   Resources: FREE! Discover the 5 Reasons Your Weight-Loss Journey Has Gotten Derailed (And How To Get Back On Track!)

We are excited to welcome our guest on this episode, Danielle Sparks. Danielle is our 2025-2026 ASHT president. During her incoming presidential address at the Annual Meeting, Danielle challenged us to consider how we can be advocates for our specialty and our patients. There are many challenges we face daily, but she shares with us how small, atomic changes can have a lasting effect. Guest Bio:Danielle Sparks, DHS, MOT, OTR, CHT is a highly experienced occupational therapist and Certified Hand Therapist with a strong clinical background in upper extremity rehabilitation. With over 15 years in the field, Danielle has spent her career at the Indiana Hand to Shoulder Center, where she has served as the Director of Therapy since 2017. Danielle graduated from Indiana University Bloomington in 2007 with a Biology degree. She earned a Master of Occupational Therapy in 2009 and then post professionally a Doctorate of Health Science in 2017, both from the University of Indianapolis. Danielle earned her Certified Hand Therapist credential in 2015. Passionate about advocacy and legislative and regulatory aspects of practicing hand therapy, Danielle has been a member of the American Society of Hand Therapists since 2012 and has been a volunteer in the Practice Division since 2017, serving as the chair from 2020-2023 and currently is serving in the ASHT Presidential line 2023-2027. Currently, Danielle is the current President for ASHT. Danielle enjoys attending courses related to upper extremity rehabilitation and the opportunity to learn from and interact with colleagues. When not involved in work related activities, Danielle enjoys traveling, kayaking, hiking, golfing, and spending time with family and her two German Shepherds. The views and opinions expressed in the Hands in Motion podcast are those of the guests and do not necessarily reflect the official policy or position of ASHT. Appearance on the podcast does not imply endorsement of any products, services or viewpoints discussed.

Sylvie Legere sits down with Dr. John Prunskis to explore the intersection of artificial intelligence and pain management. This episode unpacks the role of AI in identifying and treating chronic pain, particularly through innovative therapies like spinal cord stimulation. Dr. Prunskis shares his expertise on how AI is not only enhancing patient care but also transforming how healthcare is delivered, with a specific focus on reducing dependency on opioids. Dr. Prunskis discusses the mechanism of spinal cord stimulation, a procedure leveraging AI to dynamically interact with a patient's activity, offering personalized, non-invasive pain relief. By implementing AI, patients experience improved quality of life without the irreversible changes caused by traditional surgeries. The conversation also touches on potential hurdles, regulatory frameworks, and the exciting future of AI in healthcare, setting the stage for broader discussions at The Policy Circle Summit on AI's role across sectors.  Dr. John Prunskis Dr. John V. Prunskis, MD, FIPP, is a double-board-certified interventional pain physician internationally recognized for his leadership in pain management, regenerative medicine, and healthcare innovation. He is the founder and Chief Medical Officer of the Illinois Pain & Spine Institute, established in 1992, and currently serves as Director and Chair of the Medical Executive Committee at DxTx Pain and Spine, which he co-founded in 2020. Under his leadership, DxTx has expanded to more than 60 clinics across 10 states and delivered over one million patient visits. A 25-year Castle Connolly “Top Doctor” honoree as voted by his peers, Dr. Prunskis has dedicated his career to advancing evidence-based, minimally invasive treatments for chronic pain. Beyond clinical practice, he has played a pivotal role in shaping national policy, serving as a Presidential White House appointee to the U.S. Department of Health and Human Services Pain Management Best Practices Task Force and co-authoring its landmark 2019 Final Report. He also served three consecutive four-year terms in the Lithuanian Parliament/World Lithuanian Community Commission representing 900,000 Lithuanian Americans. For his philanthropic and professional contributions, he was bestowed the Knight of the Order of Merit by the President of Lithuania. He is Vice Chair of the American Society of Pain and Neuroscience's Artificial Intelligence (AI) Division, serves on the Advisory Board of Hippocratic AI, and is the founder of The Regenerative Stem Cell Institute. With over four decades of expertise, Dr. Prunskis bridges clinical excellence, innovation, and thoughtful public policy to expand access to ethical, effective, and technology-driven healthcare. Check out the Illinois Pain and Spine Institute's website.

Many leaders in the healthcare system and academic medicine, by default, manage their day through transactional leadership. However, as we learn in this week's episode of the Faculty Factory Podcast, there may be a better way. We are thrilled to welcome Martin Zeier, MD, visiting us from Germany this week on the podcast to discuss transformational leadership. Dr. Zeier leads the Division of Nephrology at the University of Heidelberg in Germany. He recently traveled to the United States and attended the Annual Meeting of the American Society of Nephrology, which took place in Houston. You can learn more about the University of Heidelberg here: https://www.nierenzentrum-heidelberg.com Transformational leadership helps us build trust between one another, which is one of its core principles and plays a key role in mentoring the next generation of leaders. This leadership style can strengthen our teams to advance our institutions and the missions we serve. It also challenges us to lead through intellectual stimulation, because academic professionals are not at their best without the opportunity for growth. “I have always been curious about how I could build and enhance teams and how I could improve as a medical professional and leader,” Dr. Zeier stated at the interview's outset. His own intellectual curiosity over the years served as an impetus for him to study organizational psychology in his advanced studies, as he also shared with us. Learn more about the Faculty Factory: https://facultyfactory.org/ 

A bittersweet moment for us, as the wonderful Desiree Chappell moves on to a fantastic new role in industry, after many years in the role of managing editor and anchor for TopMedTalk. This piece was recorded at ANESTHESIOLOGY® 2025 the annual general meeting of The American Society of Anesthesiology (ASA) in Chicago. Presented by Andy Cumpstey, Mike Grocott and Kate Leslie with their guest Desiree Chappell. Please make sure you are subscribed to TopMedTalk and find us on social media so we can connect online.

In this special edition of the Best Science in Lung Cancer series, host Erin Gillaspie, MD, sits down with Brendon Stiles, MD, to discuss insights from ASCO, including perioperative immunotherapy, CheckMate 816, and expanding surgical boundaries.

- Brighteon Broadcast News Introduction and Interview Announcement (0:09) - Book Project and Community Support (1:32) - Book Creation Process and AI Tools (39:17) - Book Collection and Curation (40:24) - Special Reports and AI Job Replacement (40:43) - Gold and Silver Market Analysis (1:02:47) - Book Token Usage and Loyalty Program (1:03:44) - Technical Issues and AI Tools Improvement (1:04:43) - Geopolitical Analysis and Interview with Gary Haven (1:05:07) - Christian Zionism and Its Impact (1:13:25) - Israeli Influence and Critical Thinking (1:20:04) - Challenges of Critical Thinking in Politics (1:28:10) - The Role of Media and Alternative Media (1:33:00) - The Impact of Political Decisions on American Society (1:40:59) - The Globalist Agenda and the Threat to America (1:42:15) - The Importance of Unity and Critical Thinking (1:44:04) - The Role of Independent Voters and the Future of Politics (1:45:15) - The Impact of Globalist Influence on American Society (1:48:46) - The Importance of Speaking the Truth (1:53:43) - The Role of Decentralized Information in Waking People Up (1:54:01) For more updates, visit: http://www.brighteon.com/channel/hrreport  NaturalNews videos would not be possible without you, as always we remain passionately dedicated to our mission of educating people all over the world on the subject of natural healing remedies and personal liberty (food freedom, medical freedom, the freedom of speech, etc.). Together, we're helping create a better world, with more honest food labeling, reduced chemical contamination, the avoidance of toxic heavy metals and vastly increased scientific transparency. ▶️ Every dollar you spend at the Health Ranger Store goes toward helping us achieve important science and content goals for humanity: https://www.healthrangerstore.com/ ▶️ Sign Up For Our Newsletter: https://www.naturalnews.com/Readerregistration.html ▶️ Brighteon: https://www.brighteon.com/channels/hrreport ▶️ Join Our Social Network: https://brighteon.social/@HealthRanger ▶️ Check In Stock Products at: https://PrepWithMike.com

From Season 1 – Interested in professional development as an admin or executive assistant, but unsure if it's worth it? Hear from your peers on the benefits of having a budget for training and acquiring new skills, connections, and inspiration for career advancement. Featuring APC speakers Joshua Washington and Paul Pennant; ASAP Advisory Board members Norma Lemon-Turner, Krista Hopkins, and Peyton Ticknor; and APC attendees. Recorded at the Administrative Professionals Conference 2023 and produced by the American Society of Administrative Professionals - ASAP. Learn more and submit a listener question at asaporg.com/podcast.

Actinomyces species are considered part of the normal vaginal and urogenital tract flora. The percentage of Pap smears containing Actinomyces-like organisms varies but is most commonly reported as approximately 7% among women using IUDs. That number is supported by multiple sources, including the Infectious Diseases Society of America guideline and several clinical studies. The incidence can be higher or lower depending on the type of IUD; for example, copper IUDs have been associated with rates up to 20%, while levonorgestrel-releasing IUDs show lower rates around 2.9%. In women with an IUD, who are found to have this finding on their liquid-based Pap smear, what is the appropriate management? In this episode, which comes from one of our podcast family members, we will discuss this topic and it's management in both symptomatic and symptomatic (pelvic pain) IUD wearing women. 1. McHugh KE, Sturgis CD, Procop GW, Rhoads DD. The Cytopathology of Actinomyces, Nocardia, and Their Mimickers. Diagnostic Cytopathology. 2017;45(12):1105-1115. doi:10.1002/dc.23816.2. Practice Bulletin No. 186: Long-Acting Reversible Contraception: Implants and Intrauterine Devices. Obstetrics and Gynecology. 2017;130(5):e251-e269. doi:10.1097/AOG.0000000000002400.3. Miller JM, Binnicker MJ, Campbell S, et al. Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM). Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 2024; ciae104. doi:10.1093/cid/ciae104.5. Carrara J, Hervy B, Dabi Y, et al. Added-Value of Endometrial Biopsy in the Diagnostic and Therapeutic Strategy for Pelvic Actinomycosis. Journal of Clinical Medicine. 2020;9(3):E821. doi:10.3390/jcm9030821.